from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1212c/glgA

LFCtreatmentdescriptionclass of inhibitor

-0.074

Amikacinug/mL Amikacintranslation

-0.530

Cap5-10ug/mL Capreomycintranslation

-0.470

Rox10-50 ug/mL Roxithromycintranslation

-0.278

SM2-5 ug/mL Streptomycintranslation

1.331

Tet5-10 ug/mL Tetracyclinetranslation

1.113

Rif0.2-5ug/mL Rifampicintranscription

0.297

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.010

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.903

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.133

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.189

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.234

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.631

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.096

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.846

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.391

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.340

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.429

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.018

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.053

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.448

Nigericin50 uM Nigericinrespiration

-0.241

TRC10-150 ug/mL Triclosanrespiration

0.514

TRZ10-25 ug/mL Thioridazinerespiration

-0.931

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.022

menadione6-10 ug/mL Menadionerespiration

0.157

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.179

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.912

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.169

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.054

NRP_1Non-replicating persistence stage 1dosRassociated

-0.225

Amp0.2mg/mL AmpicillincellWall

-0.543

Cephalexin20-100 ug/mL CephalexincellWall

0.176

Cerulenin0.32-5 ug/mL CerulenincellWall

0.120

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.739

EMB10-20 ug/mL EthambutolcellWall

-0.416

Eta12-40 ug/mL EthionamidecellWall

-0.600

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.186

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.493

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.472

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.677

BZA0.12 mg/mL BenzamidearomaticAmides

0.558

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.263

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.732

H2O24 mM hydrogen peroxideDNAdamaging

0.183

Levo10 ug/mL LevofloxacinDNAdamaging

0.595

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.235

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.330

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.056

UVUV-irradiationDNAdamaging

0.176

ARP41-4 ug/mL Antitubercular compound ARP4?

0.688

Antimycin12.5-50 ug/mL Antimycin A?

-0.262

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.218

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.453

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.197

PA8240.2-2 ug/mL PA-824?

-0.764

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.051

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.099

Verapamil50 uM Verapamil?

0.697

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.435

methoxatin10-20 ug/mL Methoxatin?